Thérapies de Conversion

TACE plus PD-1 successfully achieves conversion therapy for unresectable HCC with multiple macrovascular invasion: Case report.

Clin Res Hepatol Gastroenterol . 2023;47 (7) :102169

Résumé

Tous les articles